Laurus Labs (NSE:LAURUSLABS) is a leading manufacturer of Active Pharmaceutical Ingredients (API) for anti-retroviral (HIV-AIDS), oncology, nutraceutical and several other products, with a customer base that spans top-tier generic pharmaceutical companies in India and abroad. Learn more at www.lauruslabs.com.
Location: India, Telangana, Hyderabad
Employees: 1001-5000
Total raised: $89.74M
Founded date: 2005
Investors 2
Date | Name | Website |
- | F-Prime Ca... | fprimecapi... |
- | Warburg Pi... | warburgpin... |
Funding Rounds 1
Date | Series | Amount | Investors |
29.10.2014 | - | $89.74M | Warburg Pi... |
Mentions in press and media 6
Date | Title | Description | Source |
01.05.2024 | Mizoram sees alarming surge in TB deaths, 108 succumb to dis... | - | business-s... |
22.04.2024 | Stocks to Watch on April 22: RIL, HDFC Bank, Wipro, Tata Gro... | - | business-s... |
26.03.2024 | Recovery in exports amid rising chemical prices to drive SRF... | Shares of SRF, the country’s largest specialty chemicals player, hit a 10-month high last week on ex... | business-s... |
13.05.2022 | Eight Roads launches $250m fund for Indian healthcare firms | InvestmentsNewsStartups Qishin Tariq · 45m ago · 2 min readEight Roads launches $250m fund for India... | techinasia... |
29.10.2014 | Laurus Labs gets Rs 550 crore investment | Laurus Labs, the Rs 1200 crore manufacturer of Active Pharmaceutical Ingredients (APIs) has raised R... | thehindubu... |
29.10.2014 | Laurus Labs Private Limited Announces INR 550 Crore Investme... | - | warburgpin... |